Reviva Pharmaceuticals Holdings Inc. – Filings and Transcripts

NASDAQ: RVPH
Share price (3/24/26): $0.83
Market cap (3/24/26): $5.329 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Late annual filing notification for FY 2024

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Removal from listing

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

CVI Investments, Inc.

Bhat Laxminarayan

683 Capital Management, LLC

News Filter

Announces Proposed Public Offering

Material Modification to Rights of Security Holders, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Other Events, Financial Statements or Exhibits

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Other Events

Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia

Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC